The U.S. Department of Energy’s (DOE) Argonne National Laboratory is now using a combination of new and revitalized technology to develop theranostic radioisotopes — that have the potential to diagnose and treat an illness such as cancer at the same time — for the DOE’s Isotope Program. The goal is to increase their availability to researchers and hospitals, helping to develop new therapies and ultimately save lives.
The Facebook Live video below explains how Argonne scientists are making this happen.
Medical isotope production at Argonne
Everyday doctors use medical isotopes to diagnose and treat various illnesses, including cancer. In today’s program we speak with Program Manager Kawtar Hafidi and Deputy Program Manager Dave Rotsch about what medical isotopes are and what role Argonne plays in their production. For more information on Argonne’s Radioisotope Research and Production Program, please visit: https://www.anl.gov/cfc/reference/radioisotope-research-and-production-program
Posted by Argonne National Laboratory on Wednesday, January 15, 2020
Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.
The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.